Recent Finacing
Recent Raise
Ractigen Therapeutics develops saRNA-based therapies that upregulate endogenous genes, using an SCAD delivery system to enhance extrahepatic biodistribution, advancing multiple late-preclinical programs and scaling oligonucleotide manufacturing.
